Glycosylation in Cellular Mechanisms of Health and Disease

Cell

Volumn 126, Issue 5, 2006, Pages 855-867

  Ohtsubo, Kazuaki ^a   Marth, Jamey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BIOPOLYMER; CELL ENZYME; GLYCAN; GLYCOLIPID; GLYCOPEPTIDASE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; GLYCOSIDASE; GLYCOSYLTRANSFERASE; GROWTH FACTOR RECEPTOR; LAMININ; LECTIN; LECTIN RECEPTOR; LIGAND; MONOSACCHARIDE;

ANTIGEN RECOGNITION; BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL SURFACE; CLEARANCE; CONGENITAL DISORDER OF GLYCOSYLATION; DNA SEQUENCE; ENDOCYTOSIS; GAUCHER DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; GLUCURONIDATION; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; HYDROLYSIS; LYSOSOME; MOLECULAR MECHANICS; MUCOLIPIDOSIS TYPE 2; MUSCULAR DYSTROPHY; NIEMANN PICK DISEASE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SANDHOFF DISEASE; SIGNAL TRANSDUCTION; TAY SACHS DISEASE;

MAMMALIA;

EID: 33748195979     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.08.019     Document Type: Review

References (108)

1. Aebi M., and Hennet T. Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell Biol. 11 (2001) 136-141
2. Ai X., Do A.-T., Lozynska O., Kusche-Gullberg M., Lindahl U., and Emerson C.P. QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J. Cell Biol. 162 (2003) 341-351
3. Akama T.O., Nakagawa H., Sugihara K., Narisawa S., Ohyama C., Nishimura S., O'Brien D.A., Moremen K.W., Millan J.L., and Fukuda M.N. Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science 295 (2002) 124-127
4. Amado M., Almeida R., Schwientek T., and Clausen H. Identification and characterization of large galactosyltranserase gene families: galactosyltransferases for all functions. Biochim. Biophys. Acta 1473 (1999) 35-53
5. Angata K., Long J.M., Bukalo O., Lee W., Ditayev A., Wynshaw-Boris A., Schachner M., Fukuda M., and Marth J.D. Sialyltransferase ST8Sia-II assembles a subset of polysialic acid that directs hippocampal axonal targeting and promotes fear behavior. J. Biol. Chem. 279 (2004) 32603-32613
6. Ashwell G., and Harford J. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51 (1982) 531-554
7. Barton G.M., and Medzhitov R. Toll-like receptor signaling pathways. Science 300 (2003) 1524-1525
8. Belenkaya T.Y., Han C., Yan D., Opoka R.J., Khodoun M., Liu H., and Lin X. Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans. Cell 119 (2004) 231-244
9. Bessler M., Mason P.J., Hillmen P., Miyata T., Yamada N., Takeda J., Luzzatto L., and Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 13 (1994) 110-117
10. Bochner B.S., Alvarez R.A., Mehta P., Bovin N.V., Blixt O., White J.R., and Schnaar R.L. Glycan array screening reveals a candidate ligand for Siglec-8. Glycobiology 280 (2005) 4307-4312
11. Butters T.D., Dwek R.A., and Platt F.M. Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 15 (2005) 43R-52R
12. Carbone F.R., and Gleeson P.A. Carbohydrates and antigen recognition by T cells. Glycobiology 7 (1997) 725-730
13. Chen L., Zhang W., Fregien N., and Pierce M. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 17 (1998) 2087-2093
14. Chen S., Kawashima H., Lowe J.B., Lanier L.L., and Fukuda M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202 (2005) 1679-1689
15. Chui D., Sellakumar G., Green R., Sutton-Smith M., McQuistan T., Marek K., Morris H., Dell A., and Marth J.D. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc. Natl. Acad. Sci. USA 98 (2001) 1142-1147
16. Cobb B.A., and Kasper D.L. Coming of age: carbohydrates and immunity. Eur. J. Immunol. 35 (2005) 352-356
17. Collins B.E., Blixt O., DeSieno A.R., Bovin N., Marth J.D., and Paulson J.C. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Natl. Acad. Sci. USA 101 (2004) 6104-6109
18. Collins B.E., Smith B.A., Bengston P., and Paulson J.C. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat. Immunol. 7 (2006) 199-206
19. Comelli E.M., Head S.R., Gilmartin T., Whisenant T., Haslam S.M., North S.J., Wong N.K., Kudo T., Narimatsu H., Esko J.D., et al. A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology 16 (2006) 117-131
20. Crocker P.R., and Varki A. Siglecs in the immune system. Immunology 103 (2001) 137-145
21. Dell A., and Morris H.R. Glycoprotein structure determination by mass spectrometry. Science 291 (2001) 2351-2356
22. Demetriou M., Granovsky M., Quaggin S., and Dennis J. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 (2001) 733-739
23. Drickamer K., and Taylor M.E. Identification of lectins from genomic sequence data. Methods Enzymol. 362 (2003) 560-567
24. Duncan W., McCormick C., and Tufaro F. The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J. Clin. Invest. 108 (2001) 511-516
25. Ellies L.E., Ditto D., Levy G.G., Wahrenbock M., Ginsburg D., Varki A., Le D., and Marth J.D. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc. Natl. Acad. Sci. USA 99 (2002) 10042-10047
26. Esko J.D., and Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71 (2002) 435-471
27. Foulquier F., Vasile E., Schollen E., Callewaert N., Raemaekers T., Quelhas D., Jaeken J., Mills P., Winchester B., Krieger M., et al. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc. Natl. Acad. Sci. USA 103 (2006) 3764-3769
28. Freeze H.H. Genetic defects in the human glycome. Nat. Rev. Genet. 7 (2006) 537-551
29. Fukuda M., Hiraoka N., Akama T.O., and Fukuda M.N. Carbohydrate-modifying sulfotransferases: structure, function, and pathophysiology. J. Biol. Chem. 276 (2001) 47747-47750
30. Gagneux P., and Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9 (1999) 747-755
31. Goldstein I.J. Lectin structure-activity: the story is never over. J. Agric. Food Chem. 50 (2002) 6583-6585
32. Grewal P.K., Boton M., Ramirez K., Collins B.E., Saito A., Green R.S., Ohtsubo K., Chui D., and Marth J.D. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol. Cell. Biol. 26 (2006) 4970-4981
33. Haines N., and Irvine K.D. Glycosylation regulates Notch signaling. Nat. Rev. Mol. Cell Biol. 4 (2003) 786-797
34. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. USA 99 (2002) 10231-10233
35. Han S., Collins B.E., Bengston P., and Paulson J.C. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat. Chem. Biol. 1 (2005) 93-97
36. Hart G.W. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 66 (1997) 315-335
37. Helenius A., and Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73 (2004) 1019-1049
38. Hoffman S., and Edelman G.M. Kinetics of homophilic binding by embryonic and adult forms of the neural cell adhesion molecule. Proc. Natl. Acad. Sci. USA 80 (1983) 5762-5766
39. Ioffe E., and Stanley P. Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc. Natl. Acad. Sci. USA 91 (1994) 728-732
40. Ishibashi S., Hammer R.E., and Herz J. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J. Biol. Chem. 269 (1994) 27803-27806
41. Jaeken J., and Carchon H. Congenital disorders of glycosylation: a booming chapter of pediatrics. Curr. Opin. Pediatr. 16 (2004) 434-439
42. Ju T., and Cummings R.D. Protein glycosylation: chaperone mutation in Tn syndrome. Nature 437 (2005) 1252
43. Kaneko Y., Nimmerjahn F., and Ravetch J.V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313 (2006) 670-673
44. Kikuchi N., and Narimatsu H. Bioinformatics for comprehensive finding and analysis of glycosyltransferases. Biochim. Biophys. Acta 1760 (2006) 578-583
45. Kinoshita T., Ohishi K., and Takeda J. GPI-anchor synthesis in mammalian cells: genes, their products, and a deficiency. J. Biochem. (Tokyo) 122 (1997) 251-257
46. Klein A., and Roussel P. O-acetylation of sialic acids. Biochimie 80 (1998) 49-57
47. Kobata A., and Amano J. Latered glycosylatiohn of proteins produced by malignant cells, and applications in the diagnosis and immunotherapy of tumors. Immunol. Cell Biol. 83 (2005) 429-439
48. Kornfeld S., and Kornfeld R. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54 (1985) 631-644
49. Kornfeld S., and Sly W.S. Lysosomal storage defects. Hosp. Pract. 20 (1985) 71-82
50. Kudo M., Brem M.S., and Canfield W.M. Mucolipidosis II (I-cell disease) and Mucolipidosis IIIA (Classical Pseudo-Hurler Polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha/beta-subunits precursor gene. Am. J. Hum. Genet. 78 (2006) 451-463
51. Landsteiner K. Individual differences in human blood. Science 73 (1931) 405-411
52. Lau K., Partridge E.A., Cheung P., and Dennis J.W. Hexosamine, N-glycans, and cytokine signaling-a regulatory network. Glycobiology 15 (2005) 1196
53. Lee S.J., Evers S., Roeder D., Parlow A.F., Risteli J., Lee Y.C., Feizi T., Langen H., and Nussenzweig M.C. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295 (2002) 1898-1901
54. Linhardt R.J. Heparin: an important drug enters its seventh decade. Chem. Ind. 2 (1991) 45-50
55. Lowe J.B. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr. Opin. Cell Biol. 15 (2003) 531-538
56. Lowe J.B., and Marth J.D. A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72 (2003) 673-691
57. Lubke T., Marquardt T., Etzioni A., Harmann E., von Figura K., and Korner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28 (2001) 73-76
58. Maccioni H.J., Giraudo C.G., and Danniotti J.L. Understanding the stepwise synthesis of glycolipids. Neurochem. Res. 27 (2002) 629-636
59. McCaffrey G., and Jamieson J.C. Evidence for the role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialyltransferase from rat and mouse liver in whole-cell systems. Comp. Biochem. Physiol. B 104 (1993) 91-94
60. McGowan K.A., and Marinkovich M.P. Laminins and human disease. Microsc. Res. Tech. 51 (2000) 262-279
61. Metzler M., Gertz A., Sarkar M., Schachter H., Schrader J.W., and Marth J.D. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13 (1994) 2056-2065
62. Mi Y., Shapiro S.D., and Baenziger J.U. Regulation of lutropin circulatory half-life by the mannose/N-acetylgalactosamine-4-SO4 receptor is critical for implantation in vivo. J. Clin. Invest. 109 (2002) 169-170
63. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418 (2002) 376-377
64. Miljan E.A., and Bremer E.G. Regulation of growth factor receptors by gangliosides. Sci. STKE 2002 (2002) RE15
65. Morris S., Ahmad N., Andre S., Kaltner H., Gabius H.J., Brenowitz M., and Brewer F. Quaternary solution structures of galectins-1, -3, and -7. Glycobiology 14 (2004) 293-300
66. Niehues R., Hasilik M., Alton G., Korner C., Schiebe-Sukumar M., Koch H.G., Zimmer K.P., Wu R., Harms E., Reiter K., et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J. Clin. Invest. 101 (1998) 1414-1420
67. O'Donnell N., Zachara N.E., Hart G.W., and Marth J.D. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol. Cell. Biol. 24 (2004) 1680-1690
68. Ohtsubo K., Takamatsu S., Minowa M.T., Yoshida A., Takeuchi M., and Marth J.D. Dietary and genetic control of glucose transporter glycosylation promotes insulin secretion in suppressing diabetes. Cell 123 (2005) 1307-1321
69. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., and Leder P. Heparin is required for cell-free binding of fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12 (1992) 240-247
70. Parekh R.B., Swek R.A., Suttion B.J., Fernandes D.L., Leung A., Stanworth D., Rademacher T.W., Mizochi T., Taniguchi T., Matsuta K., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316 (1985) 452-457
71. Park E.I., Mi Y., Unverzagt C., Gabius H.J., and Baenziger J.U. The asiologlycoprotein receptor celars glycoconjugates terminating with sialic acid alpha 2,6GalNAc. Proc. Natl. Acad. Sci. USA 102 (2005) 17125-17129
72. Parodi A.J. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem. J. 348 (2000) 1-13
73. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., Nabi I.R., Wrana J.L., and Dennis J.W. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306 (2004) 120-124
74. Paulson J.C., Blixt O., and Collins B.E. Sweet spots in functional glycomics. Nat. Chem. Biol. 2 (2006) 238-248
75. Prescher J.A., Dube D.H., and Bertozzi C.R. Chemical remodeling of cell surfaces in living animals. Nature 430 (2004) 873-877
76. Priatel J.J., Chui D., Hiraoka N., Simmons C.J., Richardson K.B., Page D.M., Fukuda M., Varki N.M., and Marth J.D. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 12 (2000) 273-283
77. Rosen S. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22 (2004) 129-156
78. Schachter H. The joys of HexNAc. The synthesis and function of N- and O-glycan branches. Glycoconj. J. 17 (2000) 465-483
79. Schwarzkopf M., Knobeloch K.P., Rohde E., Hinderlich S., Wiechens N., Lucka L., Horak I., Reutter W., and Horstkorte R. Sialylation is essential for early development in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 5267-5270
80. Schweizer F., and Hindsgaul O. Combinatorial synthesis of carbohydrates. Curr. Opin. Chem. Biol. 3 (1999) 291-298
81. Seeberger P.H., and Werz D.B. Automated synthesis of oligosaccharides as a basis for drug discovery. Nat. Rev. Drug Discov. 4 (2005) 751-763
82. Sharon N., and Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14 (2004) 53-62
83. Shriver Z., Raguram S., and Sasisekharan R. Glycomics: A pathway to a class if new and improved therapeutics. Nat. Rev. Drug Discov. 3 (2004) 863-873
84. Shur B.D., Rodeheffer C., and Ensslin M.A. Mammalian fertilization. Curr. Biol. 14 (2004) R691-R692
85. Simpson M.A., Cross H., Proukakis C., Priestman D.A., Neville D.C., Reinkensmeier G., Wang H., Wiznitzer M., Gurtz K., Verganelaki A., et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat. Genet. 36 (2004) 1225-1229
86. Smith P.L., Myers J.T., Rogers C.E., Zhou L., Petryniak B., Becker D.J., Homeister J.W., and Lowe J.B. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J. Cell Biol. 158 (2002) 801-815
87. Sparrow D.B., Chapman G., Wouters M.A., Whittock N.V., Ellard S., Fatkin D., Turnpenny P.D., Kusumi K., Sillence D., and Dunwoodie S.L. Mutation in the LUNATIC FRINGE gene in humans causes spondylocostal dystosis with a severe vertebral phenotype. Am. J. Hum. Genet. 78 (2006) 28-37
88. Suji G., and Sivakami S. Glucose, glycation, and aging. Biogerontology 5 (2004) 365-373
89. Surani M.A. Glycoprotein synthesis and inhibition of glycosylation by tunicamycin in preimplantation mouse embryos: compaction and trophoblast adhesion. Cell 18 (1979) 217-227
90. Tabak L.A. In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. Annu. Rev. Physiol. 57 (1995) 547-564
91. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., and Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279 (2004) 17079-17084
92. Tedder T.F., Tuscano J., Sato S., and Kehrl J.H. CD22, a B lymphocyte-specific adhesion molecular that regulates antigen receptor signaling. Annu. Rev. Immunol. 15 (1997) 481-504
93. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 581-616
94. Underhill G.H., Zisoulis D.G., Kolli K.P., Ellies L.G., Marth J.D., and Kansas G.S. A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells. Blood 106 (2005) 3867-3873
95. Varki A., and Varki N.M. P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications. Braz. J. Med. Biol. Res. 34 (2001) 711-717
96. Vogt G., Chapgier A., Yang K., Chuzhanova N., Feinberg J., Fieschi C., Boisson-Dupuis S., Alcais A., Filipe-Santos O., Bustamante J., et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat. Genet. 37 (2005) 692-700
97. Wakeland E.K., Liu K., Graham R.R., and Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15 (2001) 397-408
98. Wang P., Zhang J., Bian H., Wu P., Kuvelkar R., Kung T.T., Crawley Y., Egan R.W., and Billah M.M. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem. J. 380 (2004) 425-433
99. Wang X., Inoue S., Gu J., Miyoshi E., Noda K., Li W., Mizuno-Horikawa Y., Nakano M., Asahi M., Takahashi M., et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl. Acad. Sci. USA 102 (2005) 15791-15796
100. Wang Y., Tan J., Sutton-Smith M., Ditto D., Panico M., Campbell R.M., Varki N.M., Long J.M., Jaeken J., Levinson S.M., et al. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagines-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11 (2001) 1051-1070
101. Weigel P.H., Hascall V.C., and Tammi M. Hyaluronan synthases. J. Biol. Chem. 272 (1997) 13997-14000
102. Weinhold B., Seidenfaden R., Rockle I., Muhlenhoff M., Schertzinger F., Conzelmann S., Marth J.D., Gerardy-Schahn R., and Hildebrandt H. Genetic ablation of polysialic acid causes severe neurodevelopmental defects rescued by deletion of the neural cell adhesion molecule. J. Biol. Chem. 280 (2006) 42971-42977
103. Wu X., Steet R.A., Bohorov O., Bakker J., Newell J., Krieger M., Spaapen L., Kornfeld S., and Freeze H.H. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat. Med. 10 (2004) 518-523
104. Yan A., and Lennarz W.J. Unraveling the mechanism of protein N-glycosylation. J. Biol. Chem. 280 (2005) 3121-3124
105. Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1 (2001) 717-724
106. Zachara N.E., and Hart G.W. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim. Biophys. Acta 1673 (2004) 13-28
107. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
108. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1687-1689